NFKB1 and chronic kidney disease: Liu[68] found that miR-181a can inhibit the activation of TLR/NF-KB signal pathway by down-regulating the level of target gene CRY1, delay the progression of glomerulosclerosis and tubular epithelial injury in chronic kidney disease, reduce the degree of renal injury and promote renal homeostasis.